As the world’s leading producers of UHMWPE, Orthoplastics are pleased to announce we will be attending the 9th Annual UHMWPE Conference on the 10th-11th October 2019 at the historic Union League of Philadelphia.
Not only will we be attending the event, but we are also proud to be sponsoring the event as Bronze Sponsors and our very own Managing Director, Mark Allen will be giving a keynote speech.
The conference brings together engineers, scientists, clinicians, and regulators from academia, industry and FDA to present leading-edge research on advancements in medical grade UHMWPE technology and clinical applications.
The focus of the 9th meeting is on:
- Advances in processing, crosslinking, and sterilisation of UHMWPE
- New methods of processing clinical and retrieval studies of highly crosslinked UHMWPE (HXLPE)
- The performance of thin acetabular liners and knee arthroplasty
- UHMWPE articulations with ceramic and PEEK bearing surfaces
- Vitamin E and new antioxidant technologies for UHMWPE
- Drug delivery from HXLPE
Since our investment in 3 brand new, bespoke UHMWPE (ultra-high molecular weight polyethylene) extruders we have increased our manufacturing capacity by 75% to ensure we are in the best possible position to move with orthopaedic developments as well as responding to growing market demands and patient expectations.
Mark Allen, Managing Director at Orthoplastics has been invited to be a keynote speaker at the conference, where he will be talking about ‘a new novel method for the manufacturing of highly crosslinked UHMWPE using x-ray technology.’
Mark explains more about this latest innovation saying: “STERIS have developed a new method to create high energy x-rays which allow sterilisation and chemical change in UHMWPE. This sustainable development is deemed the long term solution to Gamma processing using highly radioactive isotopes.”
We are looking forward to hearing about the latest developments and innovations at the 9th Annual UHMWPE Conference and hope to see you there.